Free & Fearless Press – Right of every Indian
Allcargo Global Logistics has informed that the board of the company has approved sub-division of the face value of equity shares of the company from Rs 10 per share to Rs 2 a share, subject to shareholders’ approval. Allcargo Global Logistics, a leading logistic service provider has entered into a joint venture agreement with Hind … Read more Allcargo Global stock split approved
Executive pilots of state-owned Air India (AI) have called off their strike following assurance from Union civil aviation minister Praful Patel. The pilots were protesting against a 50% cut in their productivity-linked incentives (PLI) and payment of their due flying allowance of three months.
The four-day strike has forced the airline to cancel over 240 flights in the last four days.
Delhi-based Fortis Healthcare, which acquired ten hospitals including two under-construction projects from Wockhardt in August this year, has decided to re-brand them as ‘Fortis Healthcare Hospitals’ after completing all acquisition related formalities that is likely to take around nine months, according to Hospitals Group CEO Vishal Bali.
Religare Technova has launched its product portal — RTGS Live. This is in line with the company’s strategy of introducing domain specific solutions. The portal is the touch-point for organisations looking for such specialised solutions and will help them in gathering of information as well as quicken the decision making process by enabling faster purchase.
The site provides a high level view of each product, which is displayed for the customers’ benefit to allow better understanding and faster decision making.
Strides Arcolab has launched its anti H1N1 drug ‘Starflu’ in the domestic retail market. Starflu is the generic version of Oseltamivir and is available in 75 mg capsules in strips of ten at Rs 460 per strip.
Strides’ move is subsequent to the Indian government’s approval of restricted retail sale of Oseltamivir (Tamiflu) for H1N1treatment. This will allow the purchase of Oseltamivir from designated chemists with Schedule X licenses, by those who have a doctor’s prescription.
Read moreStrides Arcolab announces retail launch of Oseltamivir for the treatment of H1N1
Pharma major, Orchid Chemicals & Pharmaceuticals has got some relief from the US District Court in the legal tussle with the multinational pharma major, Wyeth Pharmaceutical
The US District Court for the District of Columbia has denied Wyeth Pharmaceutical’s motion for a Temporary Restraining Order (TRO) which was filed on Wednesday in connection with its lawsuit against the US Food and Drug Administration (US FDA) challenging the latter’s approval of Orchid’s Abbreviated New Drug Applications (ANDAs) for its Zosyn generic products Piperacillin and Tazobactam for injections.
Read moreUS Court rejects Wyeth’s plea to suspend USFDA approval for Zosyn generic to Orchid